Go to homepage
Go to homepage
Your Cart
US$0.00

Antigen Peptides in Research

Antigen peptides play a key role in immunotherapy, vaccine development, and T cell response studies. JPT’s high-quality antigen peptides support groundbreaking research in cancer immunotherapy, infectious diseases, and personalized medicine. Below, you will find key studies referencing JPT’s antigen peptides in recent research.

References with Antigen Peptides

2025

2025

  • Antibody-based delivery of interleukin-2 modulates the immunosuppressive tumor microenvironment and achieves cure in pancreatic ductal adenocarcinoma syngeneic mice
    Carbone et al, Journal of Experimental & Clinical Cancer Research (2025) - PMID: 39773310
    Product used: OVA (257-264) Chicken Ovalbumin Peptide - SIINFEKL & Custom Peptides
  • Protocol to co-culture SCLC cells with human CD8+ T cells to measure tumor cell killing and T cell activation
    Chakraborty et al., STAR Protocols (2025) - PMID: 40232937
    Products used: Antigen Peptide NY-ESO-1 - HLA-A*0201 (SLLMWITQC)
  • Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity
    Emmelot et al., NPJ Vaccines (2025) - PMID: 39979288
    Product used: Custom Antigen Peptides, Custom PepMix for Measles V
  • Varicella zoster virus mRNA vaccine candidate induced superior cellular immunity and comparable humoral and Fc-mediated immunity compared to the licensed subunit vaccine in a mouse model
    Jang et al., Human Vaccines & Immunotherapeutics (2025) - PMID: 40331755
    Products used: Custom Peptide VZV gE peptide
  • ATLAS-seq: a microfluidic single-cell TCR screen for antigen-reactive TCRs
    Luo et al., Nature Communications (2025) - PMID: 39746936
    Products used: Antigen Peptide NY-ESO-1 - HLA-A*0201 (SLLMWITQC), Antigen Peptide MART-1 (Leu27) - HLA-A*0201 (ELAGIGILTV)
  • Human proteome distribution atlas for tissue-specific plasma proteome dynamics
    Malmström et al., Cell (2025) - PMID: 40203824
    Product used: Custom Peptide Synthesis
  • Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease
    Olal et al., The Journal of Infectious Diseases (2025) - PMID: 39852693
    Product used: Custom Antigen Peptide (EBOV NP–derived peptide (NP44–52) YQVNNLEEI)
  • CD8+ T cell–derived CD40L mediates noncanonicalcytotoxicity in CD40-expressing cancer cells
    Schiele et al., Science Advances (2025) - PMID: 40397730
    Products used: Simian virus 40 Large T antigen 206-215, SAINNYAQKL and Simian virus 40 Large T antigen 404-411, VVYDFLKL
  • mRNA-LNP Vaccine Strategies: Effects of Adjuvants on Non-parenchymal Liver Cells and Tolerance
    Svensson et al., Methods & Clinical Development (2025) 
    Product used: OVA (257-264) Chicken Ovalbumin Peptide - SIINFEKL
  • Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection
    Wørzner et al., eBioMedicine (2025) - PMID: 39983329
    Product used: Custom Antigen Peptides
2024

2024

  • Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness
    Bilev et al., PLoS Pathogens (2024) - PMID: 39652590
    Products used: Antigen Peptide Human CMV UL40 - HLA-E*01:01 (VMAPRTLIL), Custom Peptides
  • Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
    Neller et al., Nature Communications (2024)
    Products used: Custom Peptides
  • Phase I trial and preclinical data of ACT using neoantigen-reactive TIL for patients with advanced epithelial and ICB-resistant solid cancers
    Palomero et al., Immuno-oncology & technology (2024) 
    Products used: Custom Peptides
  • Machine learning-enhanced immunopeptidomics applied to T-cell epitope discovery for COVID-19 vaccines
    Kovalchik et al., Nature Communications (2024) 
    Products used: Antigen Peptide HIV pol HLA-A*0201 (ILKEPVHGV), CEF Pool (standard)
  • Synthesis of sulfated lactosyl glycosides for evaluation in vaccine adjuvant formulations†
    Sharma et al., New Journal of Chemistry (2024)
    Product used: Antigen Peptide Chicken Ovalbumin H-2 Kb (SIINFEKL)
  • Cytomegalovirus inhibitors of programmed cell death restrict antigen cross-presentation in the priming of antiviral CD8 T cells
    Ebert et al., PLOS Pathogens (2024) - PMID: 39146364
  • Expression of the membrane tetraspanin claudin 18 on cancer cells promotes T lymphocyte infiltration and antitumor immunity in pancreatic cancer
    De Sanctis et al., Immunity (2024)  
    Product used: Custom Antigen Peptides
  • Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo
    Azizi et al., NAR Molecular Medicine (2024) 
    Product used: Antigen Peptide Chicken Ovalbumin H-2 Kb (SIINFEKL)
  • Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity
    Hamid et al., Nature Immunology (2024) - PMID: 38561495
    Product used: Antigen Peptide Tyrosinase (Asp371) - HLA-A*0201 (YMDGTMSQV)
  • Influenza A virus-specific multifunctional memory T cells show functional superiority
    Westerhof, Dissertation (2024) 
    Product used: Antigen Peptide Influenza A NP - H2-Iab (QVYSLIRPNENPAHK), Antigen Peptide Influenza NP H-2 Db (ASNENMETM)
  • Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation
    Bérouti et al., Immunity (2024) 
  • CD8+ T Cells Mediate Lethal Lung Pathology in the Absence of PD-L1 and Type I Interferon Signalling following LCMV Infection
    Spiteri et al., Viruses (2024) - PMID: 38543756
    Products used:Antigen Peptide Nucleoprotein H-2 Db (FQPQNGQFI), Antigen Peptide Pre-glycoprotein polyprotein H-2 Db (KAVYNFATM)
  • Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection
    Clever et al., Viruses (2024) - PMID: 38543782
    Product used: Antigen Peptide IFN-gR H-2 Kb (TSYKFESV)
  • CD3-downregulation identifies T-helper-cells with superior functionality and distinct metabolism in SARS-CoV2-vaccination- and recall-antigen-specific immunity
    Sattler et al., JCI Insight (2024)
    Products used: PepMix SARS-CoV-2 (Spike B.1.1.7 / Alpha), SARS-CoV-2 Antigen Peptide Spike Fusion (SFIEDLLFNKVTLAD)
Archive

Archive

  • IFNg-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy
    Beziaud et al., Cell Stem Cell (2023) - PMID: 37267916
    Product used: Antigen Peptide Chicken Ovalbumin H-2 Kb (SIINFEKL) & Antigen Peptide gp100 H-2 Db (KVPRNQDWL)
  • Imaging of plant calcium-sensor kinase conformation monitors real time calcium decoding in planta
    Liese et al., BioRxiv (2023)
  • Identifizierung und Charakterisierung antigenspezifischer T-Zell-Antworten gegen Glioblastome
    Lu, Dissertation (2022)
  • A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained functions and TCR diversity
    Kim et al., Blood Advances (2022) - PMID: 36206199
  • Rotavirus-Induced Expansion of Antigen-Specific CD8 T Cells Does Not Require Signaling via TLR3, MyD88 or the Type I Interferon Receptor
    Muleta et al., Frontiers in Immunology (2022) 
  • Evaluation of Adjuvant Activity and Bio-Distribution of Archaeosomes Prepared Using Microfluidic Technology
    Jia et al,. Pharmaceutics (2022)
  • An experimental test of the nicotinic hypothesis of COVID-19
    Godellas et al., PNAS (2022) - PMID: 36279466
  • Mitochondrial fission induces immunoescape in solid tumors through decreasing MHC-I surface expression
    Lei et al., Nature Communication (2022) 
  • CD206+ tumor-associated macrophages cross-present tumor antigen and drive anti-tumor immunity
    Modak et al., JCI Insight (2022) - PMID: 35503656
    Products used:  Antigen Peptide NY-ESO-1 - HLA-A*0201 (SLLMWITQC)
  • Cross-Reactive CD4+ T Cells Enhance SARS-CoV-2 Immune Responses Upon Infection and Vaccination
    Lucie Loyal et.al., Science (2021) - PMID: n.a.
  • Computational design of SARS-CoV-2 spike glycoproteins to increase immunogenicity by T cell epitope engineering
    Edison Ong et al., Computational & Structural Biotechnology Journal, (2021)
  • A Method to Evaluate In Vivo CD8+ T Cell Cytotoxicity in a Murine Model
    Felicity C. Stark et al., Vaccine Delivery Technology (2020) - PMID: 32959267
  • Rational Engineering and Pre-Clinical Evaluation of Neddylation and SUMOylation Site Modified AAV Vectors in Murine Models of Hemophilia B and Leber Congenital Amarousis.
    Mr. Shubham Maurya et al., Human Gene Therapy (2019) - PMID: 31642343
  • BK Polyomavirus-Specific T Cell Immune Responses in Kidney Transplant Recipients Diagnosed with BK Polyomavirus-Associated Nephropathy
    Jackrapong Bruminhent et al., BMC Infectious Diseases (2019) - PMID: 31744480
  • Molecular Engineering of Adeno-Associated Virus Capsid Improves Its Therapeutic Gene Transfer in Murine Models of Hemophilia and Retinal Degeneration
    Bertin Mary et al., Molecular Pharmaceutics (2019) - PMID: 31596095
  • Targeted In-Vitro-Stimulation Reveals Highly Proliferative Multi-Virus-Specific Human Central Memory T Cells as Candidates for Prophylactic T Cell Therapy
    Cirac et al., Cancer Immunology, Immunotherapy (2018) - PMID: 29374782
  • Epstein–Barr Virus Strain Heterogeneity Impairs Human T-cell Immunity
    Cirac et al., Cancer Immunology, Immunotherapy (2018) - PMID: 29374782
  • T-Cell Allorecognition of Donor Glutathione S-Transferase T1 in Plasma Cell-Rich Rejection
    MJ Martínez-Bravo et al., World Journal of Hepatology (2017) - PMID: n.a.
  • Multi-Target Chimaeric VLP as a Therapeutic Vaccine in a Model of Colorectal Cancer
    Donaldson et al., J Immunother Cancer. (2017) - PMID: 28815049
  • Recombinant LCMV Vectors Induce Protective Immunity Following Homologous and Heterologous Vaccinations
    Wingerath et al., Molecular Therapy (2017) - PMID: n.a.
  • CD4 T Helper Cells Instruct Lymphopenia-Induced Memory-Like CD8 T Cells for Control of Acute LCMV Infection
    Schmitt et al., Frontiers in Immunology (2016) - PMID: n.a.
  • MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
    Romano et al., Journal of Translational Medicine (2014) - PMID: 24726012
    Products used: Antigen Peptide CMV pp65 - HLA-A*0201 (NLVPMVATV), Antigen Peptide EBV BMLF1 HLA-A*0201 (GLCTLVAML), Influenza A MP (58-66) Peptide (GILGFVFTL)
Loading...
Antigen Peptides

Check our list of products, click and go.

Get a quote